Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|October 6, 2006
Biopharmaceutical therapeutics for asthma remodelingA M Das, D E Griswold, T J Torphy, et al.
The American Journal of Physiology|December 1, 1986
Cyclic nucleotide-dependent protein kinases in the lower esophageal sphincterC A Miller, M S Barnette, H S Ormsbee, et al.
Environmental Health Perspectives|December 1, 1994
Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthmaT J Torphy, M S Barnette, D W Hay, et al.
Pulmonary Pharmacology|September 1, 1992
SK&F 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4- and antigen-induced bronchoconstriction in cynomolgus monkeysR R Osborn, D W Hay, M A Wasserman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1983
Functional antagonism in canine tracheal smooth muscle: inhibition by methacholine of the mechanical and biochemical responses to isoproterenolT J Torphy, G A Rinard, M G Rietow, et al.
Agents and Actions. Supplements|January 1, 1993
Biochemical characteristics and cellular regulation of phosphodiesterase IVT J Torphy, W E DeWolf, D W Green, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Cyclic GMP: a potential mediator of neurally- and drug-induced relaxation of opossum lower esophageal sphincterM Barnette, T J Torphy, M Grous, et al.
Molecular Pharmacology|October 1, 1996
Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram bindingS Jacobitz, M M McLaughlin, G P Livi, et al.
The Journal of Biological Chemistry|March 25, 1993
A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNAM M McLaughlin, L B Cieslinski, M Burman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
The influence of endogenous catecholamines on the inhibitory effects of rolipram against early- and late-phase response to antigen in the guinea pigD C Underwood, J K Matthews, R R Osborn, et al.
Pageof 8